BAY-184 is a selective and orally active KAT6A and KAT6B inhibitor. BAY-184 inhibits KAT6A/KAT6B activity with an IC50 of 71 nM and 83 nM. respectively BAY-184 inhibits ERalpha transcriptional activity. BAY-184 inhibits proliferation of diverse breast cancer subtypes, and inhibits tumor growth[1].
Molecular Weight:
420.48
Purity:
99.00
CAS Number:
[2520347-03-7]
Formula:
C23H20N2O4S
Target:
Estrogen Receptor/ERR,Histone Acetyltransferase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
